Team

Since our inception, Rx Bandz has been focused on providing an innovative next-generation solution for patients who carry self-injectable medication.

Photo

Rx Bandz Team

We have assembled a team of talented and experienced individuals who have the knowledge, skill, and experience required to create the next innovative and disruptive auto-injector design capable of delivering a wide range of therapeutic injectable medications.

CORPORATE

Jessica Walsh

Founder, CEO

Innovator and seasoned entrepreneur, former project manager for world-leading construction and engineering firm, business and technical experience from senior management positions in technology, business development, digital marketing, and team management, Six Sigma process improvements. Frustrated Epipen user.

Harsha Murthy

Chief Strategy Officer

A senior pharmaceutical executive with extensive experience in licensing to big pharma and direct experience with companies in the auto-injector space. Previous roles include founding private equity firms/funds (Consummate Capital and Konanda Pharma Partners) that invested in pharmaceuticals / medical devices, leadership roles at large and start-up pharmaceutical companies (King Pharmaceuticals and Eyetech Pharmaceuticals), the financial industry (GE Capital, U.S. SEC and road Ventures) and legal (Davis Polk & Wardwell and Latham & Watkins). B.A degree from Duke University and J.D. from Stanford Law School.

Myrna Walsh

Chief Administrative Officerer

Former Executive Director of Massachusetts hospital system foundation. Published author. Successfully raised millions of dollars for healthcare in grants. Municipal capital budget advisory board member. Launched hospice from concept to Medicare-ready. Frustrated EpiPen user.

James DeAngelis

Strategic Advisor

25 years of corporate finance experience in companies with environmental and biotech focus; 18 years as C-Level Executive with strategic development in intellectual property, including manufacturing processes, laboratory analysis for early FDA approval applications, multi-million dollar exits, and IPO.

Medical Team

Dr. Michael Blaiss MD

FACAAI - Chief Medical Officer

Clinical Professor of Pediatrics and Medicine, University of Tennessee Health Science Center. Executive Medical Director, American College of Allergy, Asthma, and Immunology. He was a past Medical Director for Pfizer and Merck.

Dr. Sean Hollonbeck

Chief Administrative Officerer

The retired Colonel has 31 years of experience leading large organizations, from the Chief Medical Officer of two Army Installations to the DoD Medical Research and Development laboratory. He led a CDMRP multiservice grant funding line. Dr. Hollonbeck has served as an expert witness and was rated in Material Contracting and Acquisitions.

Dr. Robert Carr MD

Military Medical Advisor

Dr. Bob Carr is a retired AF flight surgeon and human performance /preventative medicine specialist. He was most recently the President of the American College of Preventive Medicine and Senior Vice President & Corporate Medical Director at the global healthcare firm GlaxoSmithKline.

Perry Molinoff, MD

Pharmaceutical Advisorer

Dr. Molinoff's background includes more than thirty years of experience in both the academic and industrial sectors. He is a professor of Pharmacology Emeritus at the University of Pennsylvania. He is also Chairman of the Innovation Support Center Panel at Harrington Discovery Institute. Previously he directed research at Palatin Technologies and Bristol-Meyers Squibb Pharmaceutical Research Institute.

Julie DeAngelis Ph.D

Health Economics Advisor

18 years of diverse pharmaceutical experience with leadership positions in marketing, clinical development, health economics, and outcomes research with Astellas Pharmaceuticals.

Obinna Anosike, MD

Medical Research

Rutgers Robert Wood Johnson Medical School. Held position as an M1 course facilitator guiding learning, brainstorming, and problem-solving of medical case-based problems. Masters in Biomedical Science DNJ-Stratford.

Development/ Manufacturing

Stephen Harhen

Chief Technology Officer dvisorer

Biomaterials and mechanical engineer. He previously was a Research and Development Engineer for Ethicon, a Johnson and Johnson Company. He is currently a Ph.D. candidate (Mechanical Engineering) at Villanova University and holds an MS (Biomedical Engineering) from the New Jersey Institute of Technology and a BS (Biomedical Engineering) from Rutgers University School of Engineering.

Thomas Gardner

VP of Regulatory Affairsnomics Advisor

Mr. Gardner was formerly the Subject Matter Expert on Regulatory, Quality, Product Development, Commercialization, and Technology for the Air Force’s 59th Medical Wing Science and Technology. He was Vice President for the Military Health Research Foundation and has 30 years in the medical product industry as a scientist, manufacturing, quality management, and product development manager for a large CMO.

E Paul Harhen

Engineering Advisor

39 years experience in engineering, medical device product design/testing for manufacture, and support, including clinical trials for FDA submission. Successfully developed numerous products and brought them to launch. Holds 28 US patentr guiding learning, brainstorming, and problem-solving of medical case-based problems. Masters in Biomedical Science DNJ-Stratford.